One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
BJD: striving to be the Best Journal in Dermatology in a changing world
doi : 10.1093/bjd/ljae169
Volume 191, Issue 1, July 2024
Biomarkers as key concepts in managing atopic dermatitis and psoriasis: unlocking new ways of care for patients with chronic hand dermatoses
doi : 10.1093/bjd/ljae127
Survival is not enough: understanding the mental burden of cutaneous melanoma
doi : 10.1093/bjd/ljae050
Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab
doi : 10.1093/bjd/ljae036
Debunking the myth that all emollients are equal opens the door for future atopic dermatitis prevention studies
doi : 10.1093/bjd/ljae146
Are perinatal antibiotics responsible for atopic dermatitis? The debate rages on
doi : 10.1093/bjd/ljad477
Food for thought: a comment on ‘Breastfeeding decreases the risk of developing psoriasis through to early adulthood’
doi : 10.1093/bjd/ljae135
Discovering skin-rejuvenating matrikines: a new frontier in basic and applied dermatology
doi : 10.1093/bjd/ljae100
GLMN variants cause skin hyperpigmentation: a promising potential therapeutic target
doi : 10.1093/bjd/ljae149
Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma
doi : 10.1093/bjd/ljae092
Using artificial intelligence-based technologies to support the diagnosis and early detection of melanoma in primary care
doi : 10.1093/bjd/ljae094
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective
doi : 10.1093/bjd/ljae080
Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression
doi : 10.1093/bjd/ljae011
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS)
doi : 10.1093/bjd/ljad523
Frequent oil baths and skin barrier during infancy in the PreventADALL study
doi : 10.1093/bjd/ljae091
In utero or early-in-life exposure to antibiotics and the risk of childhood atopic dermatitis, a population-based cohort study
doi : 10.1093/bjd/ljad428
Breastfeeding decreases the risk of developing psoriasis through to early adulthood
doi : 10.1093/bjd/ljae043
Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure
doi : 10.1093/bjd/ljae019
Towards a patient-centred definition for atopic dermatitis flare: a qualitative study of adults with atopic dermatitis
doi : 10.1093/bjd/ljae037
Prediction, screening and characterization of novel bioactive tetrapeptide matrikines for skin rejuvenation
doi : 10.1093/bjd/ljae061
Loss-of-function variants in GLMN are associated with generalized skin hyperpigmentation with or without glomuvenous malformation
doi : 10.1093/bjd/ljae108
Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study
doi : 10.1093/bjd/ljae053
Evaluation of an artificial intelligence-based decision support for the detection of cutaneous melanoma in primary care: a prospective real-life clinical trial
doi : 10.1093/bjd/ljae021
Time for ‘the change’: increasing awareness of the menopause transition in dermatological training and practice
doi : 10.1093/bjd/ljae044
Potential digenic inheritance of SERPINB7 and SERPINA12 variants in Chinese patients with Nagashima-type palmoplantar keratosis
doi : 10.1093/bjd/ljae134
Combined rituximab and belimumab to treat recalcitrant epidermolysis bullosa aquisita associated with systemic lupus erythematosus
doi : 10.1093/bjd/ljae141
Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit
doi : 10.1093/bjd/ljae136
Trends in antibiotic prescriptions for hidradenitis suppurativa from 2015 to 2021
doi : 10.1093/bjd/ljae155
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study)
doi : 10.1093/bjd/ljae153
Antifungal-resistant Trichophyton indotineae: transmission is occurring outside previously identified endemic areas – are we prepared?
doi : 10.1093/bjd/ljae140
Antifungal-resistant Trichophyton indotineae: transmission warrants priority attention and international collaboration
doi : 10.1093/bjd/ljae162
Progressive hyperpigmentation and lentigines due to KIT variants improving with imatinib
doi : 10.1093/bjd/ljae109
Correction to: Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization
doi : 10.1093/bjd/ljae204
Long-term response to treatment with guselkumab in people with moderate-to-severe psoriasis
doi : 10.1093/bjd/ljae235
